91 related articles for article (PubMed ID: 1476554)
21. Genetic aspects on the effects of ethanol and central stimulants on locomotor activity and brain dopamine metabolism in mice.
Liljequist S; Karcz-Kubicha M
Alcohol Alcohol Suppl; 1993; 2():457-61. PubMed ID: 7748339
[TBL] [Abstract][Full Text] [Related]
22. Calcium channel antagonists attenuate cross-sensitization to the locomotor effects of nicotine and ethanol in mice.
Biała G; Weglińska B
Pol J Pharmacol; 2004; 56(4):391-7. PubMed ID: 15520492
[TBL] [Abstract][Full Text] [Related]
23. Dissociation between the locomotor and anxiolytic effects of acetaldehyde in the elevated plus-maze: evidence that acetaldehyde is not involved in the anxiolytic effects of ethanol in mice.
Tambour S; Didone V; Tirelli E; Quertemont E
Eur Neuropsychopharmacol; 2005 Dec; 15(6):655-62. PubMed ID: 15950440
[TBL] [Abstract][Full Text] [Related]
24. [Reproductive toxicity of metadoxine in rats].
Wang Y; Zhu HJ; Lai WQ; Chen JG; Mei S; Zhang WY; Zhang X
Zhonghua Yu Fang Yi Xue Za Zhi; 2003 May; 37(3):178-82. PubMed ID: 12880564
[TBL] [Abstract][Full Text] [Related]
25. Individual differences to repeated ethanol administration may predict locomotor response to other drugs, and vice versa.
Abrahao KP; Quadros IM; Souza-Formigoni ML
Behav Brain Res; 2009 Feb; 197(2):404-10. PubMed ID: 18984011
[TBL] [Abstract][Full Text] [Related]
26. [Effects of metadoxine on main biohumoral changes induced by chronic alcoholism].
Corsini G; Gelso E; Giuliano G
Clin Ter; 1992 Mar; 140(3):251-7. PubMed ID: 1568369
[TBL] [Abstract][Full Text] [Related]
27. MK-801 blocks the development of behavioral sensitization to the ethanol.
Camarini R; Frussa-Filho R; Monteiro MG; Calil HM
Alcohol Clin Exp Res; 2000 Mar; 24(3):285-90. PubMed ID: 10776664
[TBL] [Abstract][Full Text] [Related]
28. Ascorbic acid effect on ethanol sensitivity via possible dopaminergic mediation.
Yanai J; Fishman RH; Mittleman L
Subst Alcohol Actions Misuse; 1984; 5(4):169-74. PubMed ID: 6523349
[TBL] [Abstract][Full Text] [Related]
29. Common quantitative trait loci for alcohol-related behaviors and central nervous system neurotensin measures: locomotor activation.
Erwin VG; Radcliffe RA; Gehle VM; Jones BC
J Pharmacol Exp Ther; 1997 Feb; 280(2):919-26. PubMed ID: 9023307
[TBL] [Abstract][Full Text] [Related]
30. Liver triglyceride accumulation after chronic ethanol administration: a possible protective role of metadoxina and ubiquinone.
Marchi S; Polloni A; Costa F; Bellini M; Bonifazi V; Tumino E; Grassi B; Romano MR; De Bartolo G; Bertelli A
Int J Tissue React; 1990; 12(4):247-50. PubMed ID: 2283204
[TBL] [Abstract][Full Text] [Related]
31. [Metadoxine in alcohol-related pathology].
Santoni S; Corradini P; Zocchi M; Camarri F
Clin Ter; 1989 Jul; 130(2):115-22. PubMed ID: 2529084
[TBL] [Abstract][Full Text] [Related]
32. Concurrent administration of diethyldithiocarbamate and 4-methylpyrazole enhances ethanol-induced locomotor activity: the role of brain ALDH.
Escarabajal MD; Aragon CM
Psychopharmacology (Berl); 2002 Apr; 160(4):339-43. PubMed ID: 11919660
[TBL] [Abstract][Full Text] [Related]
33. MK-801-induced locomotor activity in long-sleep x short-sleep recombinant inbred mouse strains: correlational analysis with low-dose ethanol and provisional quantitative trait loci.
Zahniser NR; Negri CA; Hanania T; Gehle VM
Alcohol Clin Exp Res; 1999 Nov; 23(11):1721-9. PubMed ID: 10591587
[TBL] [Abstract][Full Text] [Related]
34. The 5-HT3 receptor antagonist, ondansetron, blocks the development and expression of ethanol-induced locomotor sensitization in mice.
Umathe SN; Bhutada PS; Raut VS; Jain NS; Mundhada YR
Behav Pharmacol; 2009 Feb; 20(1):78-83. PubMed ID: 19106764
[TBL] [Abstract][Full Text] [Related]
35. [The therapeutic effect of metadoxine on alcoholic and non-alcoholic steatohepatitis].
Váli L; Blázovics A; Fehér J
Orv Hetil; 2005 Nov; 146(47):2409-14. PubMed ID: 16398154
[TBL] [Abstract][Full Text] [Related]
36. Gender specific effects of ethanol in mice, lacking CCK2 receptors.
Abramov U; Raud S; Innos J; Kõks S; Matsui T; Vasar E
Behav Brain Res; 2006 Nov; 175(1):149-56. PubMed ID: 16970998
[TBL] [Abstract][Full Text] [Related]
37. Preliminary findings on the use of metadoxine for the treatment of alcohol dependence and alcoholic liver disease.
Leggio L; Kenna GA; Ferrulli A; Zywiak WH; Caputo F; Swift RM; Addolorato G
Hum Psychopharmacol; 2011 Dec; 26(8):554-9. PubMed ID: 22095793
[TBL] [Abstract][Full Text] [Related]
38. Pharmacology, Systematic Review and Recent Clinical Trials of Metadoxine.
Di Miceli M; Gronier B
Rev Recent Clin Trials; 2018; 13(2):114-125. PubMed ID: 29485008
[TBL] [Abstract][Full Text] [Related]
39. Changes in expression of the albumin, fibronectin and type I procollagen genes in CCl4-induced liver fibrosis: effect of pyridoxol L,2-pyrrolidon-5 carboxylate.
Arosio B; Santambrogio D; Gagliano N; Annoni G
Pharmacol Toxicol; 1993 Dec; 73(6):301-4. PubMed ID: 7512265
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of metadoxine in the management of acute alcohol intoxication.
Díaz Martínez MC; Díaz Martínez A; Villamil Salcedo V; Cruz Fuentes C
J Int Med Res; 2002; 30(1):44-51. PubMed ID: 11921498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
